메뉴 건너뛰기




Volumn 109, Issue 6, 2012, Pages 403-407

Short-acting β-agonist use and its ability to predict future asthma-related outcomes

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; LEUKOTRIENE RECEPTOR AFFECTING AGENT; LONG ACTING DRUG; METHYLXANTHINE DERIVATIVE; NEDOCROMIL; OMALIZUMAB;

EID: 84869864081     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2012.08.014     Document Type: Article
Times cited : (161)

References (24)
  • 1
    • 79955951398 scopus 로고    scopus 로고
    • Vital signs: Asthma prevalence, disease characteristics, and self-management education: United States, 2001-2009
    • Centers for Disease Control and Prevention
    • Centers for Disease Control and Prevention Vital signs: asthma prevalence, disease characteristics, and self-management education: United States, 2001-2009 MMWR Morb Mortal Wkly Rep 60 2011 547 552
    • (2011) MMWR Morb Mortal Wkly Rep , vol.60 , pp. 547-552
  • 2
    • 84871113089 scopus 로고    scopus 로고
    • American College of Allergy, Asthma & Immunology (ACAAI) Accessed October 2011.
    • American College of Allergy, Asthma & Immunology (ACAAI). Who has asthma and why? Available at http://www.acaai.org/allergist/asthma/Pages/what- causes-asthma.aspx. Accessed October 2011.
    • Who Has Asthma and Why?
  • 3
    • 77955541269 scopus 로고    scopus 로고
    • National Asthma Education and Prevention Program (NAEPP) expert panel report 3: Guidelines for the diagnosis and management of asthma
    • National Asthma Education and Prevention Program (NAEPP) Expert Panel
    • National Asthma Education and Prevention Program (NAEPP) Expert Panel National Asthma Education and Prevention Program (NAEPP) expert panel report 3: guidelines for the diagnosis and management of asthma J Allergy Clin Immunol 120 2007 S94 S138
    • (2007) J Allergy Clin Immunol , vol.120
  • 4
    • 79952116401 scopus 로고    scopus 로고
    • Medical therapy for asthma: Updates from the NAEPP guidelines
    • K.S. Elward, and S.M. Pollart Medical therapy for asthma: updates from the NAEPP guidelines Am Fam Physician 82 2010 1242 1251
    • (2010) Am Fam Physician , vol.82 , pp. 1242-1251
    • Elward, K.S.1    Pollart, S.M.2
  • 5
    • 79960547699 scopus 로고    scopus 로고
    • Prescription patterns for asthma medications in children and adolescents with health care insurance in the United States
    • F.M. Arellano, A. Arana, C.E. Wentworth, C.F. Vidaurre, and B.E. Chipps Prescription patterns for asthma medications in children and adolescents with health care insurance in the United States Pediatr Allergy Immunol 22 2011 469 476
    • (2011) Pediatr Allergy Immunol , vol.22 , pp. 469-476
    • Arellano, F.M.1    Arana, A.2    Wentworth, C.E.3    Vidaurre, C.F.4    Chipps, B.E.5
  • 6
  • 7
    • 51649128297 scopus 로고    scopus 로고
    • Asthma quality-of-care measures using administrative data: Relationships to subsequent exacerbations in multiple databases
    • M. Schatz, and D. Stempel Asthma quality-of-care measures using administrative data: relationships to subsequent exacerbations in multiple databases Ann Allerg Asthma Immunol 101 2008 235 239
    • (2008) Ann Allerg Asthma Immunol , vol.101 , pp. 235-239
    • Schatz, M.1    Stempel, D.2
  • 8
    • 55849118034 scopus 로고    scopus 로고
    • Relationship between recent short-acting beta-agonist use and subsequent asthma exacerbations
    • J. Paris, E.L. Peterson, and K. Wells Relationship between recent short-acting beta-agonist use and subsequent asthma exacerbations Ann Allergy Asthma Immunol 101 2008 482 487
    • (2008) Ann Allergy Asthma Immunol , vol.101 , pp. 482-487
    • Paris, J.1    Peterson, E.L.2    Wells, K.3
  • 9
    • 77955532317 scopus 로고    scopus 로고
    • Quarterly assessment of short-acting beta(2)-adrenergic agonist use as a predictor of subsequent health care use for asthmatic patients in the United States
    • H.S. Silver, C.M. Blanchette, and S. Kamble Quarterly assessment of short-acting beta(2)-adrenergic agonist use as a predictor of subsequent health care use for asthmatic patients in the United States J Asthma 47 2010 660 666
    • (2010) J Asthma , vol.47 , pp. 660-666
    • Silver, H.S.1    Blanchette, C.M.2    Kamble, S.3
  • 10
    • 33746397649 scopus 로고    scopus 로고
    • Administrative claims analysis of asthma-related health care utilization for patients who received inhaled corticosteroids with either montelukast or salmeterol as combination therapy
    • F.C. Allen-Ramey, D. Bukstein, A. Luskin, S.G. Sajjan, and L.E. Markson Administrative claims analysis of asthma-related health care utilization for patients who received inhaled corticosteroids with either montelukast or salmeterol as combination therapy J Manag Care Pharm 12 2006 310 321
    • (2006) J Manag Care Pharm , vol.12 , pp. 310-321
    • Allen-Ramey, F.C.1    Bukstein, D.2    Luskin, A.3    Sajjan, S.G.4    Markson, L.E.5
  • 11
    • 0035117447 scopus 로고    scopus 로고
    • Double trouble: Impact of inappropriate use of asthma medication on the use of health care resources
    • A.H. Anis, L.D. Lynd, X.H. Wang, and G. King Double trouble: impact of inappropriate use of asthma medication on the use of health care resources CMAJ 164 2001 625 631
    • (2001) CMAJ , vol.164 , pp. 625-631
    • Anis, A.H.1    Lynd, L.D.2    Wang, X.H.3    King, G.4
  • 12
    • 77952832447 scopus 로고    scopus 로고
    • Relationship of asthma control to asthma exacerbations using surrogate markers within a managed care database
    • M. Schatz, R.S. Zeiger, and S.J. Yang Relationship of asthma control to asthma exacerbations using surrogate markers within a managed care database Am J Manag Care 16 2010 327 333
    • (2010) Am J Manag Care , vol.16 , pp. 327-333
    • Schatz, M.1    Zeiger, R.S.2    Yang, S.J.3
  • 14
    • 23744500514 scopus 로고    scopus 로고
    • Short-acting beta-agonist prescription fills as a marker for asthma morbidity
    • E.T. Naureckas, V. Dukic, X. Bao, and P. Rathouz Short-acting beta-agonist prescription fills as a marker for asthma morbidity Chest 128 2005 602 608
    • (2005) Chest , vol.128 , pp. 602-608
    • Naureckas, E.T.1    Dukic, V.2    Bao, X.3    Rathouz, P.4
  • 15
    • 0032411766 scopus 로고    scopus 로고
    • Treatment of Medicaid patients with asthma: Comparison with treatment guidelines using disease-based drug utilization review methodology
    • J.M. Laumann, and D.C. Bjornson Treatment of Medicaid patients with asthma: comparison with treatment guidelines using disease-based drug utilization review methodology Ann Pharmacother 32 1998 1290 1294
    • (1998) Ann Pharmacother , vol.32 , pp. 1290-1294
    • Laumann, J.M.1    Bjornson, D.C.2
  • 17
    • 84869083832 scopus 로고    scopus 로고
    • Demographic and comorbid disparities based on payer type in a total joint arthroplasty cohort: Implications in a changing health care arena
    • L.C. Warth, J.J. Callaghan, C.W. Wells, S.S. Liu, A. Klaassen, Y. Gao, and R.C. Johnston Demographic and comorbid disparities based on payer type in a total joint arthroplasty cohort: implications in a changing health care arena Iowa Orthop J 31 2011 64 68
    • (2011) Iowa Orthop J , vol.31 , pp. 64-68
    • Warth, L.C.1    Callaghan, J.J.2    Wells, C.W.3    Liu, S.S.4    Klaassen, A.5    Gao, Y.6    Johnston, R.C.7
  • 18
    • 84871172742 scopus 로고    scopus 로고
    • The Henry J. Kaiser Family Foundation Distribution of the Nonelderly with Medicaid by Gender, states (2009-2010), U.S. (2010). Accessed April 22, 2011.
    • The Henry J. Kaiser Family Foundation Distribution of the Nonelderly with Medicaid by Gender, states (2009-2010), U.S. (2010). Available at http://www.statehealthfacts.org/comparebar.jsp?ind=157&cat=3. Accessed April 22, 2011.
  • 19
    • 84928697800 scopus 로고    scopus 로고
    • Summary health statistics for U.S. adults: National Health Interview Survey, 2008
    • J.R. Pleis, J.W. Lucas, and B.W. Ward Summary health statistics for U.S. adults: National Health Interview Survey, 2008 Vital Health Stat 10 242 2009 1 157
    • (2009) Vital Health Stat 10 , vol.242 , pp. 1-157
    • Pleis, J.R.1    Lucas, J.W.2    Ward, B.W.3
  • 20
    • 42049110725 scopus 로고    scopus 로고
    • Insurance status and asthma-related health care utilization in patients with severe asthma
    • A.T. Peters, J.C. Klemens, and T. Haselkorn Insurance status and asthma-related health care utilization in patients with severe asthma Ann Allergy Asthma Immunol 100 2008 301 307
    • (2008) Ann Allergy Asthma Immunol , vol.100 , pp. 301-307
    • Peters, A.T.1    Klemens, J.C.2    Haselkorn, T.3
  • 21
    • 4243500233 scopus 로고    scopus 로고
    • Tape TG University of Nebraska Medical Center
    • Tape TG. Interpreting diagnostic tests. University of Nebraska Medical Center. Available at http://gim.unmc.edu/dxtests.
    • Interpreting Diagnostic Tests
  • 22
    • 0842263890 scopus 로고    scopus 로고
    • Asthma population management: Development and validation of a practical 3-level risk stratification scheme
    • M. Schatz, R. Nakahiro, C.H. Jones, R.M. Roth, A. Joshua, and D. Petitti Asthma population management: development and validation of a practical 3-level risk stratification scheme Am J Manag Care 10 2004 25 32
    • (2004) Am J Manag Care , vol.10 , pp. 25-32
    • Schatz, M.1    Nakahiro, R.2    Jones, C.H.3    Roth, R.M.4    Joshua, A.5    Petitti, D.6
  • 23
    • 84871123958 scopus 로고    scopus 로고
    • ®. National Committee for Quality Assurance website Accessed September 28, 2011
    • ®. National Committee for Quality Assurance website http://www.ncqa.org/tabid/59/default. aspx Accessed September 28, 2011
  • 24
    • 79951825567 scopus 로고    scopus 로고
    • Relationship between short-acting â2-adrenergic agonist use and healthcare costs
    • H.S. Silver, C.M. Blanchette, and S. Kamble Relationship between short-acting â2-adrenergic agonist use and healthcare costs Am J Manag Care 17 2011 19 27
    • (2011) Am J Manag Care , vol.17 , pp. 19-27
    • Silver, H.S.1    Blanchette, C.M.2    Kamble, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.